[go: up one dir, main page]

FI950229A0 - Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina - Google Patents

Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina

Info

Publication number
FI950229A0
FI950229A0 FI950229A FI950229A FI950229A0 FI 950229 A0 FI950229 A0 FI 950229A0 FI 950229 A FI950229 A FI 950229A FI 950229 A FI950229 A FI 950229A FI 950229 A0 FI950229 A0 FI 950229A0
Authority
FI
Finland
Prior art keywords
intermediates
processes
preparation
antitumor agents
tetracyclic compounds
Prior art date
Application number
FI950229A
Other languages
English (en)
Swedish (sv)
Other versions
FI950229L (fi
FI950229A7 (fi
Inventor
Karl Witold Franzmann
Jeremy Nigel Stables
Patrick Vivian Richard Shannon
Nagaraja Kodanda Ranganath Rao
Laddawan Chunchatprasert
Original Assignee
Wellcome Found
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Univ Cardiff filed Critical Wellcome Found
Publication of FI950229A0 publication Critical patent/FI950229A0/fi
Publication of FI950229L publication Critical patent/FI950229L/fi
Publication of FI950229A7 publication Critical patent/FI950229A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI950229A 1992-07-20 1993-07-19 Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistami seksi ja niiden käyttö kasvaintenvastaisina aineina FI950229A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215361A GB9215361D0 (en) 1992-07-20 1992-07-20 Heterocyclic compounds
PCT/GB1993/001512 WO1994002483A1 (en) 1992-07-20 1993-07-19 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents

Publications (3)

Publication Number Publication Date
FI950229A0 true FI950229A0 (fi) 1995-01-19
FI950229L FI950229L (fi) 1995-03-10
FI950229A7 FI950229A7 (fi) 1995-03-10

Family

ID=10718981

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950229A FI950229A7 (fi) 1992-07-20 1993-07-19 Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistami seksi ja niiden käyttö kasvaintenvastaisina aineina

Country Status (23)

Country Link
EP (1) EP0651750A1 (fi)
JP (1) JPH08502037A (fi)
KR (1) KR950702563A (fi)
CN (1) CN1088209A (fi)
AU (1) AU4579593A (fi)
BG (1) BG99359A (fi)
CA (1) CA2140662A1 (fi)
CZ (1) CZ14995A3 (fi)
FI (1) FI950229A7 (fi)
GB (1) GB9215361D0 (fi)
HR (1) HRP931066A2 (fi)
HU (1) HUT76787A (fi)
IL (1) IL106385A0 (fi)
MX (1) MX9304355A (fi)
NO (1) NO950202D0 (fi)
NZ (1) NZ254207A (fi)
PL (1) PL307169A1 (fi)
RU (1) RU95104939A (fi)
SI (1) SI9300390A (fi)
SK (1) SK7595A3 (fi)
WO (1) WO1994002483A1 (fi)
YU (1) YU50293A (fi)
ZA (1) ZA935213B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401921D0 (en) * 1994-02-01 1994-03-30 Wellcome Found Heterocyclic compounds
GB9413758D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Heterocyclic compounds
GB9804343D0 (en) * 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
ATE431823T1 (de) * 2001-02-14 2009-06-15 Wisconsin Alumni Res Found Zubereitungen und verwendung eines ah-rezeptor- liganden, 2-(1'h-indol-3'-carbonyl)-thiazol-4- carbonsäure-methylester
US7419992B2 (en) 2001-02-14 2008-09-02 Wisconsin Alumni Research Foundation Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US20100130579A1 (en) * 2006-10-23 2010-05-27 Georgetown University Cancer therapy
BRPI0917411A2 (pt) 2008-08-15 2015-12-01 Univ Georgetown composto de dansil-carbazol, método para tratamento de câncer em um sujeito, método para reduzir atividade de mentiltransferase de dna em uma célula, método para aumentar expressão da associação de dominio da familia 1a(rassf1a) em uma célula, métodos de identificação de célula, método de determinação se uma ou mais células de um sujeito são células cancerosas, composição farmacêutica e kit.
JP2012051804A (ja) * 2008-12-26 2012-03-15 Kyoto Univ Eg5阻害剤
KR20160066490A (ko) 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 헤테로사이클 유도체 및 그의 용도
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
CN109776550B (zh) * 2019-01-17 2021-08-10 广东轻工职业技术学院 一种海洋真菌来源的生物碱化合物及其在制备食品防腐剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300688A1 (en) * 1987-07-21 1989-01-25 FISONS plc Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
GB2239013B (en) * 1989-11-01 1993-06-02 Toyama Chemical Co Ltd Novel isoindole derivatives and salts thereof,processes for producing the same and antitumor agent comprising the same
EP0447703A1 (en) * 1990-03-20 1991-09-25 The Wellcome Foundation Limited Hetero polycyclic biocidal compounds, their synthesis and intermediates therefor,formulations containing them and their use in medicine

Also Published As

Publication number Publication date
SI9300390A (en) 1994-03-31
FI950229L (fi) 1995-03-10
ZA935213B (en) 1995-01-19
PL307169A1 (en) 1995-05-15
SK7595A3 (en) 1995-07-11
MX9304355A (es) 1994-04-29
JPH08502037A (ja) 1996-03-05
WO1994002483A1 (en) 1994-02-03
GB9215361D0 (en) 1992-09-02
KR950702563A (ko) 1995-07-29
NO950202L (no) 1995-01-19
RU95104939A (ru) 1996-10-27
HU9500171D0 (en) 1995-03-28
AU4579593A (en) 1994-02-14
CN1088209A (zh) 1994-06-22
NZ254207A (en) 1997-03-24
HUT76787A (en) 1997-11-28
NO950202D0 (no) 1995-01-19
YU50293A (sh) 1997-01-08
CA2140662A1 (en) 1994-02-03
HRP931066A2 (en) 1995-12-31
BG99359A (bg) 1995-11-30
FI950229A7 (fi) 1995-03-10
CZ14995A3 (en) 1995-10-18
EP0651750A1 (en) 1995-05-10
IL106385A0 (en) 1993-11-15

Similar Documents

Publication Publication Date Title
FI932961L (fi) Metallocener med arylsubsituerade indenylderivat som ligander, foerfarande foer framstaellning av dessa och anvaendning av dessa som katalysatorer
FI963283A0 (fi) 4-asemasta heterosyklyylillä substituoituja kinatsoliinijohdannaisia, menetelmiä niiden valmistamiseksi ja niiden käyttö syöpälääkkeinä
FI934109L (fi) Bensoylguanidiner, foerfarande foer framstaellning av dessa, deras anvaendning som laekemedel och laekemedel innehaollande dessa
FI932659L (fi) Gallsyraderivat, foerfaranden foer deras framstaellning och anvaendning avdessa foereningar som laekemedel
FI930970A7 (fi) Imidazolderivat med bifenylsulfonylurea- eller bifenylsulfonyluretansidokedja, foerfaranden foer framstaellning av dessa och anvaendning av dessa
FI951722A0 (fi) Uudet substituoidut pyratsolijohdannaiset, menetelmät niiden valmistamiseksi ja niiden käyttö herbisideinä
FI925926L (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
FI931608L (fi) Foerfarande och anordning foer terapeutisk, elektromagnetisk behandling
FI931901L (fi) Azolfoereningar, deras framstaellning och anvaendning
FI931305A7 (fi) Imidazolfoereningar, deras framstaellning och bruk
FI930620A0 (fi) Bensimidazolylderivat, dessa foereningar innehaollande laekemedel och foerfarande foer deras framstaellning
FI933856A7 (fi) Foerfarande och anordning behandling av organiska aemnen, speciellt spillvatten som innehaoller organiska klorfoereningar fraon epiklorhydrinframstaellning
FI965020A7 (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI925924L (fi) Hydrerat staerkelsehydrolysat med laog kariesframkallande effekt, foerfarande foer framstaellning av detta och tillaempningen av detta hydrolysat
FI931336L (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
FI932625A0 (fi) Anordning och foerfarande foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter
FI930977L (fi) Taxanderivat, deras framstaellning och onkologiska anvaendning
FI950229A0 (fi) Tetrasyklisiä yhdisteitä, menetelmä ja välituotteita niiden valmistamiseksi ja niiden käyttö kasvaintenvastaisina aineina
FI932255L (fi) Alkalinproteaser, bakterier producerande dem, foerfarande foer framstaellning av dessa alkalinproteaser, anvaendning av dessa alkalinproteaser och tvaettmedelskompositioner innehaollande dem
FI934621L (fi) Pyrazolo 4,3-c pyridiner, foerfarande foer framstaellning av dessa och anvaendning av dessa som serotoninaoterupptagningsinhibitorer
FI930264A7 (fi) 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxokinolinderivat saosom antihyperkolesterolemiska och antiaterosklerotiska medel
FI931599L (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
FI102169B (fi) 3-aminopyrrolit, menetelmä niiden valmistamiseksi ja niiden käyttö lää keaineina
FI905191A7 (fi) Bensocykloalylaminopyridinaminer och motsvarande föreningar, förfarande och mellanprodukter för deras framställning och deras användning som läkemedel